Tumor-associated macrophages: potential therapeutic strategies and future prospects in cancer
Open accessThe DOI matches its Crossref record; 221 of the 221 references it cites were found in a registry or an index.
Abstract
Macrophages are the most important phagocytes in vivo. However, the tumor microenvironment can affect the function and polarization of macrophages and form tumor-associated macrophages (TAMs). Usually, the abundance of TAMs in tumors is closely associated with poor prognosis. Preclinical studies have identified important pathways regulating the infiltration and polarization of TAMs during tumor progression. Furthermore, potential therapeutic strategies targeting TAMs in tumors have been studied, including inhibition of macrophage recruitment to tumors, functional repolarization of TAMs toward an antitumor phenotype, and other therapeutic strategies that elicit macrophage-mediated extracellular phagocytosis and intracellular destruction of cancer cells. Therefore, with the increasing impact of tumor immunotherapy, new antitumor strategies to target TAMs are now being discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“TAMs also secrete TGF-β, which recruits and activates Tregs that participate in immunosuppression [96].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [96]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–221 of 221
Webb, M. W., Sun, J., Sheard, M. A., Liu, W., Wu, H., Jackson, J. R., Malvar, J., Sposto, R., Daniel, D., & Seeger, R. C. (2018) · International Journal of Cancer · doi:10.1002/ijc.31532 · Cited by 51
de Silva, S., Fromm, G. J., Shuptrine, C. W., Johannes, K., Patel, A., Yoo, K. J., Huang, K., & Schreiber, T. H. (2020) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-19-0493 · Cited by 51
Tellechea, M., Buxadé, M., Tejedor, S., Aramburu, J., & López-Rodríguez, C. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1601942 · Cited by 50
Zhang, Q., Li, Y., Miao, C., Wang, Y., Xu, Y., Dong, R., Zhang, Z., Griffin, B. B., Yuan, C., Yan, S., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.05.049 · Cited by 48
On macrophage diversity and inflammatory metabolic timers
Murray, P. J. (2019) · Nature reviews. Immunology · doi:10.1038/s41577-019-0260-2 · Cited by 47
Guida, M., Guida, M., Felice, B. D., Santafede, D., D‘Alessandro, R., Sardo, A. D. S., Scognamiglio, M., Ferrara, C., Bifulco, G., & Nappi, C. (2010) · BioMed Research International · doi:10.1155/2010/251767 · Cited by 47
Rhee, A. J., & Lavine, K. J. (2020) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021119-034412 · Cited by 46
Li, F., Okreglicka, K. M., Pohlmeier, L. M., Schneider, C., & Kopf, M. (2020) · The EMBO Journal · doi:10.15252/embj.2019103205 · Cited by 44
The Role of Macrophages in the Activation of T and B Lymphocytes in Vitro
Rosenstreich, D. L., & Oppenheim, J. J. (1976) · Elsevier eBooks · doi:10.1016/b978-0-12-514550-3.50013-x · Cited by 40
Immunological Control of Macrophage Proliferation In Vivo
North, R. J., & Mackaness, G. B. (1973) · Infection and Immunity · doi:10.1128/iai.8.1.68-73.1973 · Cited by 36
Taniyama, D., Taniyama, K., Kuraoka, K., Zaitsu, J., Saito, A., Nakatsuka, H., Sakamoto, N., Sentani, K., Oue, N., & Yasui, W. (2017) · Gastric Cancer · doi:10.1007/s10120-017-0713-x · Cited by 35
Inhibition of the SRC Kinase HCK Impairs STAT3-Dependent Gastric Tumor Growth in Mice
Poh, A. R., Dwyer, A. R., Eissmann, M. F., Chand, A. L., Baloyan, D., Boon, L., Murrey, M. W., Whitehead, L. W., O'Brien, M., Lowell, C. A., et al. (2020) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-19-0623 · Cited by 35
Alaeddine, M., Prat, M., Poinsot, V., Gouazé‐Andersson, V., Authier, H., Meunier, É., Lefèvre, L., Alric, C., Dardenne, C., Bernad, J., et al. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0213 · Cited by 34
The transcription factor NFAT5 limits infection-induced type I interferon responses
Encabo, H. H., Traveset, L., Argilaguet, J. M., Angulo, A., Nistal‐Villán, E., Jaiswal, R., Escalante, C. R., Gekas, C., Meyerhans, A., Aramburu, J. F., et al. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20190449 · Cited by 31
Preventive Inhibition of Liver Tumorigenesis by Systemic Activation of Innate Immune Functions
Lee, J., Liao, R., Wang, G., Yang, B.-H., Luo, X., Varki, N. M., Qiu, S., Ren, B., Fu, W., & Feng, G. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.10.064 · Cited by 26
Yeh, Y., Hsu, S.-J., Lin, P., Hsu, K., Wu, P., Su, W., Chang, J., & Shen, M. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1007 · Cited by 22
Monocyte subsets in myocardial infarction: A review
Arfvidsson, J., Ahlin, F., Vargas, K. G., Thaler, B., Wojta, J., & Huber, K. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.12.182 · Cited by 14
The Yolk Sac Feeds Pancreatic Tumors
Pollard, J. W. (2017) · Immunity · doi:10.1016/j.immuni.2017.07.021 · Cited by 7
CD24 Is a “Don't Eat Me” Signal That Promotes Tumor Immune Escape
(2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-rw2019-123 · Cited by 7
"Cloaking" on Time: A Cover-Up Act by Resident Tissue Macrophages.
Blériot, C., Ng, L.-G., & Ginhoux, F. (2019) · Cell · doi:10.1016/j.cell.2019.03.042 · Cited by 5
Abstract 4160: PZP as a new gene associated with increased breast cancer risk
Kuligina, E. S., Соколенко, А. П., Kumar, R. C., Валерьевич, Б. И., Iyevleva, A. G., Zagorodnev, K. A., Hasan, S. K., Romanko, A. A., Varma, A. K., & Имянитов, Е. Н. (2019) · Epidemiology · doi:10.1158/1538-7445.sabcs18-4160 · Cited by 3
Research works printed but not linked: 1
- Metchnikoff E. Untersuchungen über die mesodermalen Phagocyten einiger Wirbeltiere. Biologisches centralblatt 1883; 3: 560– 5.
Cited by
Macrophages in immunoregulation and therapeutics
Chen, S., Saeed, A. F. U. H., Liu, Q., Jiang, Q., Xu, H., Xiao, G. G., Rao, L., & Duo, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01452-1 · Cited by 2,229
M1/M2 macrophages and their overlaps – myth or reality?
Strizova, Z., Benesova, I., Bartolini, R., Novysedlak, R., Cecrdlova, E., Foley, L. K., & Striz, I. (2023) · Clinical Science · doi:10.1042/cs20220531 · Cited by 612
Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets
Tie, Y., Tang, F., Wei, Y.-Q., & Wei, X.-W. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01282-8 · Cited by 591
Role of the CCL2‐CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting
Xu, M., Wang, Y., Xia, R., Wei, Y., & Wei, X. (2021) · Cell Proliferation · doi:10.1111/cpr.13115 · Cited by 382
Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets
Guan, F., Wang, R., Yi, Z., Luo, P., Liu, W., Xie, Y., Liu, Z., Xia, Z., Zhang, H., & Cheng, Q. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02124-y · Cited by 371
Metadata
- Authors
- Li, C., Xu, X., Wei, S., Jiang, P., Xue, L., & Wang, J.
- Affiliations
- Peking University Third Hospital (CN)
- Corresponding author
- Li, Chunxiao
- Jiang, Ping
- Xue, Lixiang
- Wang, Junjie
- Venue
- Journal for ImmunoTherapy of Cancer
- Publisher
- BMJ
- Published
- 2021-01
- Volume
- 9
- Issue
- 1
- Pages
- e001341
- ISSN
- 2051-1426 (ISSN-L)
- PMC
- PMC8728363
- OpenAlex
- W3124610114
- Cited by
- 360
- References
- 221
- Citations by year
- 2026: 59 · 2025: 111 · 2024: 90 · 2023: 60 · 2022: 33 · 2021: 6
- FWCI
- 4.98
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal for ImmunoTherapy of Cancer (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (81803051)
- China Postdoctoral Science Foundation (2017M620545, 2018T110015)
- Natural Science Foundation of Beijing Municipality (7192220)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- tumor-associated macrophages, macrophage polarization, tumor microenvironment, TAM infiltration, TAM-targeted therapy, TAM repolarization, phagocytosis, cancer immunotherapy, prognosis
- MeSH terms
- Tumor-Associated Macrophages, Antineoplastic Agents, Humans, Neoplasms, Phagocytosis, Prognosis, Cell Polarity, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.